No Data
No Data
No Data
No Data
No Data
Owning 36% Shares,institutional Owners Seem Interested in Shattuck Labs, Inc. (NASDAQ:STTK),
Yahoo FinanceApr 18 21:05
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
TipRanksApr 12 19:00
Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)
TipRanksApr 11 00:10
Shattuck Labs Reports Preclinical Data Demonstrating Therapeutic Utility Of TRIM7 Inhibition To Prevent Or Reverse Acquired Resistance To Immune Checkpoint Therapy
These data were featured in an oral presentation during the AACR Annual Meeting 2024, being held from April 5-10, 2024, in San Diego, California.
BenzingaApr 10 04:15
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired resistance to PD-1/L1
GlobeNewswireApr 10 04:05
Needham: Reiterates Shattuck Labs (STTK.US) rating and adjusted from buy to buy rating, target price is $12.00.
Needham: Reiterates Shattuck Labs (STTK.US) rating and adjusted from buy to buy rating, target price is $12.00.
Zhitong FinanceApr 9 18:27
No Data
No Data